Health
Papalekas In Talks With Ovidiu Buluc To Buy Former Farmexim Platform
Greek businessman Ioannis Papalekas, one of the most dynamic real estate investors of Bucharest in recent years, is in talks with businessman Ovidiu Buluc to acquire a 26,000-sqm land plot i...
A&D Pharma Group Turnover Topped EUR1B In 2013
Pharmaceutical group A&D Pharma had a turnover of RON4.7 billion (EUR1.07 billion) in 2013, up 6.7% on the year, as its distribution division Mediplus and Sensiblu drugstores had higher sale...
RomGerMed, In Talks With Strategic Investors For Over EUR10M Cash Inflow
Private healthcare group RomGerMed is “in advanced talks” with strategic investors in a bid to secure a capital inflow of more than EUR10 million, company officials said, without providing f...
World Bank Approves $339M Healthcare Loan To Romania
The World Bank’s Board of Executive Directors approved Friday a $338.8 million loan to Romania to improve the country’s healthcare infrastructure, the bank said in a statement.
Roche: Romania, Not A Strategic Country For Us
Roche Romania, the largest player on the domestic pharmaceutical market, is likely to downwardly revise its 5% revenue growth projection announced previously, as the update of the list of re...
Dragos Damian Re-elected Head Of Association Of Generic Drug Producers In Romania
Dragos Damia, general manager of generic drug maker Terapia-Ranbaxy, has been re-elected president of the Association of Generic Medicine Producers in Romania (APMGR).
Antibiotice, Biofarm or Zentiva: Which Pharma Stock To Invest In?
Zentiva Bucuresti (SCD.RO) is paying the highest dividend of all pharmaceutical producers listed on the Bucharest stock market, while Biofarm (BIO.RO) will not be paying any. Analysts’ favor...
Renewed Interest For Healthcare Deals: Medas and RomGerMed, In Talks With Investors
Healthcare market deals are likely to return into the limelight this year as two Romanian medium-sized operators, Medas and RomGerMed, are in talks to attract investors in the companies.
Zentiva Romania Mulls Paying 50% Higher Dividends Of RON30M For 2013
Drugmaker Zentiva Romania (SCD.RO) plans to pay out its shareholders total dividends worth RON30 million (EUR6.7 million), 50% higher on the year and nearly three quarters of its 2013 net pr...